RESMODI Trademark of Modig Life Sciences, Inc. - Serial Number 98580707

Trademark Overview

On Sunday, June 2, 2024, a trademark application was filed for RESMODI with the United States Patent and Trademark Office. The USPTO has given the RESMODI trademark a serial number of 98580707. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, June 3, 2024. This trademark is owned by Modig Life Sciences, Inc.. The RESMODI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neurological, psychiatric, neurodegenerative and rare diseases, disorders and conditions

General Information

Serial Number	98580707
Word Mark	RESMODI
Filing Date	Sunday, June 2, 2024
Status	630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status Date	Monday, June 3, 2024
Registration Number	0000000
Registration Date	NOT AVAILABLE
Mark Drawing	4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition Date	NOT AVAILABLE

Trademark Statements

Goods and Services

Pharmaceutical preparations for the treatment of neurological, psychiatric, neurodegenerative and rare diseases, disorders and conditions

Classification Information

International Class	005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes	005, 006, 018, 044, 046, 051, 052
Class Status Code	6 - Active
Class Status Date	Sunday, June 2, 2024
Primary Code	005
First Use Anywhere Date	NOT AVAILABLE
First Use In Commerce Date	NOT AVAILABLE

Trademark Owner History

Party Name	Modig Life Sciences, Inc.
Party Type	10 - Original Applicant
Legal Entity Type	99 - Other
Address	New York, NY 10023

Trademark Events

Event Date	Event Description
Monday, June 3, 2024	NEW APPLICATION ENTERED

Related Keywords

resmodi rare diseases disorders conditions neurodegenerative psychiatric preparations treatment neurological pharmaceutical